Evidence Synthesis
Here's the standard_shift narrative based on the provided JSON payload: SMSPHARMA has accelerated its 34.14% gross margin, up from 12.51%.
The company's marginal operating leverage has also seen a significant increase, up from 11.5%.
However, the company's revenue growth rate has decelerated, down from 49.2%. Additionally, the daily volume has decreased, moving from 424932 shares to 318052 shares.
The close price has also seen a decline, moving from 423.5 INR to 403.25 INR.
By paying you agree to our Terms and Privacy Policy.